Efficacy of lamivudine in chronic hepatitis B patients with active viral replication and decompensated cirrhosis undergoing liver transplantation.
暂无分享,去创建一个
D. Tyrrell | N. Kneteman | L. Jewell | G. Tipples | K. Fischer | V. Bain | M. Ma | J. Shapiro | K. Gutfreund | H. Lee
[1] D. Tyrrell,et al. Mutation in HBV RNA‐dependent DNA polymerase confers resistance to lamivudine in vivo , 1996, Hepatology.
[2] E. Schiff,et al. A preliminary trial of lamivudine for chronic hepatitis B infection. , 1995, The New England journal of medicine.
[3] H. Conjeevaram,et al. Hepatic failure and lactic acidosis due to fialuridine (FIAU), an investigational nucleoside analogue for chronic hepatitis B. , 1995, The New England journal of medicine.
[4] J. Montaner,et al. A phase I/II study of 2'-deoxy-3'-thiacytidine (lamivudine) in patients with advanced human immunodeficiency virus infection. , 1995, The Journal of infectious diseases.
[5] R. Tubiana,et al. Evaluation of safety and efficacy of 3TC (lamivudine) in patients with asymptomatic or mildly symptomatic human immunodeficiency virus infection: a phase I/II study. , 1995, The Journal of infectious diseases.
[6] R. Zetterman. Liver transplantation for hepatitis B: where do we go from here? , 1995, The American journal of gastroenterology.
[7] M. Loriot,et al. Pretransplantation interferon treatment and recurrence of hepatitis B virus infection after liver transplantation for hepatitis B–related end‐stage liver disease , 1994, Hepatology.
[8] G. Alexander,et al. Liver transplantation in European patients with the hepatitis B surface antigen. , 1993, The New England journal of medicine.
[9] A. Mason,et al. Hepatitis B and liver transplantation. Problems and promises. , 1993, The New England journal of medicine.
[10] M. Wick,et al. Hepatitis B virus replication in diverse cell types during chronic hepatitis B virus infection , 1993, Hepatology.
[11] T. Wright. The threat of hepatitis B virus recurrence: A sword of damocles to the liver transplant recipient , 1993, Hepatology.
[12] J. Cameron,et al. Effects of (-)-2'-deoxy-3'-thiacytidine (3TC) 5'-triphosphate on human immunodeficiency virus reverse transcriptase and mammalian DNA polymerases alpha, beta, and gamma , 1992, Antimicrobial Agents and Chemotherapy.
[13] S. Davies,et al. Hepatitis B virus reinfection after orthotopic liver transplantation. Serological and clinical implications. , 1992, Journal of hepatology.
[14] W. Bechstein,et al. Follow-up of recurrent hepatitis B and delta infection in liver allograft recipients after treatment with recombinant interferon-alpha. , 1991, Journal of hepatology.
[15] C. Wittekind,et al. Liver transplantation in HBs antigen (HBsAg) carriers. Prevention of hepatitis B virus (HBV) recurrence by passive immunization. , 1991, Journal of hepatology.
[16] D. Samuel,et al. Passive immunoprophylaxis after liver transplantation in HBsAg-positive patients , 1991, The Lancet.
[17] J. Lake,et al. Liver transplantation for patients with hepatitis B: What have we learned from our results? , 1991, Hepatology.
[18] D. V. van Thiel,et al. Orthotopic liver transplantation for patients with hepatitis B virus–related liver disease , 1991, Hepatology.
[19] R Williams,et al. Hepatic histological findings after transplantation for chronic hepatitis B virus infection, including a unique pattern of fibrosing cholestatic hepatitis , 1991, Hepatology.